(Q36848804)

16 August 2017

1 reference

title

Glucocorticoid-induced osteoporosis: pathophysiology and therapy (English)

1 reference

glucocorticoid-induced osteoporosis

16 August 2017

0 references

1 reference

1 reference

E Canalis

1

1 reference

16 August 2017

G Mazziotti

series ordinal

2

1 reference

16 August 2017

A Giustina

series ordinal

3

1 reference

16 August 2017

J P Bilezikian

series ordinal

4

1 reference

16 August 2017

language of work or name

English

0 references

publication date

14 June 2007

1 reference

Osteoporosis International

16 August 2017

published in

1 reference

16 August 2017

volume

18

1 reference

16 August 2017

issue

10

1 reference

16 August 2017

page(s)

1319-1328

1 reference

Effect of glucocorticoids on type I collagen synthesis, alkaline phosphatase activity, and deoxyribonucleic acid content in cultured rat calvariae

16 August 2017

cites work

1 reference

12 December 2020

Glucocorticoid-induced osteoporosis: an update

1 reference

12 December 2020

Transgenic mice overexpressing insulin-like growth factor binding protein-5 display transiently decreased osteoblastic function and osteopenia

1 reference

12 December 2020

Effect of cortisol on periosteal and nonperiosteal collagen and DNA synthesis in cultured rat calvariae

1 reference

12 December 2020

The C/EBP family of transcription factors.

1 reference

12 December 2020

Is bone mineral density predictive of fracture risk reduction?

1 reference

12 December 2020

Glucocorticoids inhibit the transcriptional activity of LEF/TCF in differentiating osteoblasts in a glycogen synthase kinase-3beta-dependent and -independent manner

1 reference

12 December 2020

Bone resorption by osteoclasts

1 reference

12 December 2020

Cortisol downregulates osteoblast alpha 1 (I) procollagen mRNA by transcriptional and posttranscriptional mechanisms.

1 reference

12 December 2020

Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human.

1 reference

12 December 2020

Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group

1 reference

12 December 2020

Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation

1 reference

12 December 2020

The Comparative Efficacy of Drug Therapies Used for the Management of Corticosteroid-Induced Osteoporosis: A Meta-Regression

1 reference

12 December 2020

Changes in serum receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, and interleukin-6 levels in patients with glucocorticoid-induced osteoporosis treated with human parathyroid hormone (1-34).

1 reference

12 December 2020

Effects of cortisol and bone morphogenetic protein-2 on stromal cell differentiation: correlation with CCAAT-enhancer binding protein expression

1 reference

12 December 2020

Induction of peroxisome proliferator-activated receptor gamma during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPbeta, C/EBPdelta, and glucocorticoids

1 reference

12 December 2020

Practice patterns in patients at risk for glucocorticoid-induced osteoporosis

1 reference

12 December 2020

Trends in prevention of glucocorticoid-induced osteoporosis

1 reference

12 December 2020

Bone histomorphometry and structure in corticosteroid treated chronic active hepatitis

1 reference

12 December 2020

Body composition and vertebral fracture risk in female patients treated with glucocorticoid.

1 reference

12 December 2020

Episodic secretion of parathyroid hormone in postmenopausal women: assessment by deconvolution analysis and approximate entropy

1 reference

12 December 2020

Caspases: enemies within

1 reference

12 December 2020

Dexamethasone promotes expression of membrane-bound macrophage colony-stimulating factor in murine osteoblast-like cells

1 reference

12 December 2020

Risedronate therapy prevents corticosteroid-induced bone loss: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study

1 reference

12 December 2020

Bone density variation and its effects on risk of vertebral deformity in men and women studied in thirteen European centers: the EVOS Study.

1 reference

12 December 2020

Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme

1 reference

12 December 2020

C/EBP regulates hepatic transcription of 11beta -hydroxysteroid dehydrogenase type 1. A novel mechanism for cross-talk between the C/EBP and glucocorticoid signaling pathways

1 reference

12 December 2020

Osteoblastic cells regulate the haematopoietic stem cell niche

1 reference

12 December 2020

Two polymorphisms in the glucocorticoid receptor gene directly affect glucocorticoid-regulated gene expression.

1 reference

12 December 2020

Glucocorticoid-treated mice have localized changes in trabecular bone material properties and osteocyte lacunar size that are not observed in placebo-treated or estrogen-deficient mice

1 reference

12 December 2020

Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength

1 reference

12 December 2020

Glucocorticoids suppress bone formation via the osteoclast

1 reference

12 December 2020

Growth hormone response to growth hormone-releasing hormone is reduced in adult asthmatic patients receiving long-term inhaled corticosteroid treatment

1 reference

12 December 2020

Modulation of 11beta-hydroxysteroid dehydrogenase isozymes by proinflammatory cytokines in osteoblasts: an autocrine switch from glucocorticoid inactivation to activation

1 reference

12 December 2020

Clinical utility of microarchitecture measurements of trabecular bone

1 reference

12 December 2020

Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy

1 reference

12 December 2020

Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial. European Corticosteroid-Induced Osteoporosis Treatment Study

1 reference

12 December 2020

Daily treatment with parathyroid hormone is associated with an increase in vertebral cross-sectional area in postmenopausal women with glucocorticoid-induced osteoporosis.

1 reference

12 December 2020

11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response

1 reference

12 December 2020

Growth hormone in glucocorticoid-induced osteoporosis

1 reference

12 December 2020

CCAAT/enhancer binding protein homologous protein (DDIT3) induces osteoblastic cell differentiation

1 reference

12 December 2020

Glucocorticoid regulation of insulin-like growth factor-binding protein expression in normal human osteoblast-like cells

1 reference

12 December 2020

Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women

1 reference

12 December 2020

Clinical review 151: The role of parathyroid hormone in the pathogenesis of glucocorticoid-induced osteoporosis: a re-examination of the evidence

1 reference

12 December 2020

Arginine normalizes the growth hormone (GH) response to GH-releasing hormone in adult patients receiving chronic daily immunosuppressive glucocorticoid therapy

1 reference

12 December 2020

Bone formation by osteocytes

1 reference

12 December 2020

Secreted antagonists of the Wnt signalling pathway

1 reference

12 December 2020

Prevention of glucocorticoid-induced apoptosis in osteocytes and osteoblasts by calbindin-D28k

1 reference

12 December 2020

Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial

1 reference

12 December 2020

The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis

1 reference

12 December 2020

Glucocorticoids induce the differentiation of a mesenchymal progenitor cell line, ROB-C26 into adipocytes and osteoblasts, but fail to induce terminal osteoblast differentiation

1 reference

12 December 2020

Mechanisms of glucocorticoid action in bone

1 reference

12 December 2020

Impaired cortical bone acquisition and osteoblast differentiation in mice with osteoblast-targeted disruption of glucocorticoid signaling.

1 reference

12 December 2020

The pathogenesis, epidemiology and management of glucocorticoid-induced osteoporosis

1 reference

12 December 2020

The essential role of glucocorticoids for proper human osteoblast differentiation and matrix mineralization

1 reference

12 December 2020

Mean wall thickness and formation periods of trabecular bone packets in corticosteroid-induced osteoporosis

1 reference

12 December 2020

Rationale for treatment of involutional osteoporosis in women and for prevention and treatment of corticosteroid-induced osteoporosis with alfacalcidol

1 reference

12 December 2020

Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis

1 reference

12 December 2020

Prevention and treatment of glucocorticoid-induced osteoporosis with active vitamin D3 analogues: a review with meta-analysis of randomized controlled trials including organ transplantation studies

1 reference

12 December 2020

High-dose glucocorticoid treatment induces rapid loss of trabecular bone mineral density and lean body mass

1 reference

12 December 2020

Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial

1 reference

12 December 2020

Osteoblastic 11beta-hydroxysteroid dehydrogenase type 1 activity increases with age and glucocorticoid exposure

1 reference

12 December 2020

Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis

1 reference

12 December 2020

Effects of recombinant human growth hormone (GH) on bone and intermediary metabolism in patients receiving chronic glucocorticoid treatment with suppressed endogenous GH response to GH-releasing hormone

1 reference

12 December 2020

Low-dose parathyroid hormone and estrogen reverse alkaline phosphatase activity suppressed by dexamethasone in mouse osteoblastic cells

1 reference

12 December 2020

Standards for performing DXA in individuals with secondary causes of osteoporosis

1 reference

12 December 2020

US and UK guidelines for glucocorticoid-induced osteoporosis: similarities and differences

1 reference

12 December 2020

High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy: a cross-sectional outpatient study

1 reference

12 December 2020

Short-term increases in bone turnover markers predict parathyroid hormone-induced spinal bone mineral density gains in postmenopausal women with glucocorticoid-induced osteoporosis

1 reference

12 December 2020

Cortisol Increases Interstitial Collagenase Expression in Osteoblasts by Post-transcriptional Mechanisms

1 reference

12 December 2020

Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy

1 reference

12 December 2020

Skeletal morbidity in inflammatory bowel disease

1 reference

12 December 2020

Perspectives on glucocorticoid-induced osteoporosis

1 reference

12 December 2020

Wnt signaling in osteoblasts and bone diseases

1 reference

12 December 2020

[Biochemical markers of bone in steroid (glucocorticoid)-induced osteoporosis (GIOP)]

1 reference

12 December 2020

Osteoporosis after solid organ and bone marrow transplantation

1 reference

12 December 2020

Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density

1 reference

12 December 2020

Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. A randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas

1 reference

12 December 2020

Calcium and vitamin D in the prevention and treatment of osteoporosis - a clinical update

1 reference

12 December 2020

The ER22/23EK polymorphism in the glucocorticoid receptor gene is associated with a beneficial body composition and muscle strength in young adults

1 reference

12 December 2020

Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone

1 reference

12 December 2020

Regulation of parathyroid hormone (PTH)/PTH-related peptide receptor messenger ribonucleic acid by glucocorticoids and PTH in ROS 17/2.8 and OK cells

1 reference

12 December 2020

High-dose glucocorticoids increase serum levels of soluble IL-6 receptor alpha and its ratio to soluble gp130: an additional mechanism for early increased bone resorption

1 reference

12 December 2020

Pulsatile secretion of parathyroid hormone in normal young subjects: assessment by deconvolution analysis

1 reference

12 December 2020

Glucocorticoid suppresses the canonical Wnt signal in cultured human osteoblasts.

1 reference

12 December 2020

Bone loss in inflammatory arthritis: mechanisms and therapeutic approaches with bisphosphonates

1 reference

12 December 2020

The Vitamin D requirement in health and disease

1 reference

12 December 2020

Cortisol inhibits the synthesis of insulin-like growth factor-binding protein-5 in bone cell cultures by transcriptional mechanisms

1 reference

12 December 2020

Chronic glucocorticoid treatment alters spontaneous pulsatile parathyroid hormone secretory dynamics in human subjects

1 reference

12 December 2020

Thiazolidinedione use and bone loss in older diabetic adults

1 reference

12 December 2020

An association between respiratory function and bone mineral density in women from the general community: a cross sectional study.

1 reference

12 December 2020

Insulin-like growth factor I mediates selective anabolic effects of parathyroid hormone in bone cultures

1 reference

12 December 2020

Bone structure in patients with low bone mineral density with or without vertebral fractures

1 reference

12 December 2020

Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy

1 reference

12 December 2020

Differential effects of glucocorticoids on cortical appendicular and cortical vertebral bone mineral content

1 reference

12 December 2020

Oral glucocorticoid use is associated with an increased risk of fracture

1 reference

12 December 2020

Alfacalcidol inhibits bone resorption and stimulates formation in an ovariectomized rat model of osteoporosis: distinct actions from estrogen

1 reference

12 December 2020

Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men.

1 reference

12 December 2020

Identification of the BclI polymorphism in the glucocorticoid receptor gene: association with sensitivity to glucocorticoids in vivo and body mass index

1 reference

12 December 2020

The risk of osteoporosis in Caucasian men and women with obstructive airways disease.

1 reference

12 December 2020

Osteoporosis associated with excess glucocorticoids

1 reference

12 December 2020

Management of glucocorticoid induced osteoporosis in premenopausal women with autoimmune disease

1 reference

12 December 2020

Myostatin gene deletion prevents glucocorticoid-induced muscle atrophy

1 reference

12 December 2020

Cortisol represses insulin-like growth factor II receptor transcription in skeletal cell cultures

1 reference

12 December 2020

Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis.

1 reference

12 December 2020

Active acromegaly enhances spontaneous parathyroid hormone pulsatility

1 reference

12 December 2020

Essential role of beta-catenin in postnatal bone acquisition

1 reference

12 December 2020

Prednisolone-induced Ca2+ malabsorption is caused by diminished expression of the epithelial Ca2+ channel TRPV6.

1 reference

12 December 2020

Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis

1 reference

12 December 2020

Dexamethasone enhances osteoclast formation synergistically with transforming growth factor-beta by stimulating the priming of osteoclast progenitors for differentiation into osteoclasts.

1 reference

12 December 2020

10.1007/S00198-007-0394-0

Identifiers

DOI

1 reference

16 August 2017

1 reference